GINA DAVIS: Open Payments
NPI 1669474631 · AVON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 27 payments from 8 companies in 2025. Trend: 2023 $3,414 · 2024 $3,065 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $141 |
| ABBVIE INC. | 5 | $107 |
| MDD US Operations, LLC | 3 | $57 |
| Dexcom, Inc. | 3 | $47 |
| LivaNova USA, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $31 |
| Cala Health, Inc. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $22 |
Products named: KESIMPTA, VYALEV, Dexcom G6 Transmitter, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Apokyn, BOTOX, The Cologuard Plus Collection Kit, Cala kIQ.
Industry payments across IN — which companies pay providers there.
